Business Description
HPGC Renmintongtai Pharmaceutical Corp
NAICS : 325412
ISIN : CNE000000G05
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.91 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | 2.73 | |||||
Interest Coverage | 17.25 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.9 | |||||
Beneish M-Score | -2.24 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.2 | |||||
3-Year EBITDA Growth Rate | 20.5 | |||||
3-Year EPS without NRI Growth Rate | 27.2 | |||||
3-Year Book Growth Rate | 11.4 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 79.99 | |||||
9-Day RSI | 64.76 | |||||
14-Day RSI | 58.18 | |||||
6-1 Month Momentum % | -14.04 | |||||
12-1 Month Momentum % | -6.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 40.13 | |||||
Days Sales Outstanding | 150.49 | |||||
Days Payable | 108.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 5.27 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 9.63 | |||||
Operating Margin % | 4.3 | |||||
Net Margin % | 2.89 | |||||
FCF Margin % | 0.12 | |||||
ROE % | 11.11 | |||||
ROA % | 4.08 | |||||
ROIC % | 11.6 | |||||
ROC (Joel Greenblatt) % | 17.98 | |||||
ROCE % | 14.91 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 12.99 | |||||
PE Ratio without NRI | 12.3 | |||||
Shiller PE Ratio | 15.56 | |||||
Price-to-Owner-Earnings | 13.51 | |||||
PEG Ratio | 2.41 | |||||
PS Ratio | 0.37 | |||||
PB Ratio | 1.37 | |||||
Price-to-Tangible-Book | 1.38 | |||||
Price-to-Free-Cash-Flow | 318.57 | |||||
Price-to-Operating-Cash-Flow | 109.67 | |||||
EV-to-EBIT | 9.17 | |||||
EV-to-EBITDA | 9.17 | |||||
EV-to-Revenue | 0.38 | |||||
EV-to-FCF | 306.41 | |||||
Price-to-Projected-FCF | 1.79 | |||||
Price-to-DCF (Earnings Based) | 1.07 | |||||
Price-to-DCF (FCF Based) | 27.88 | |||||
Price-to-Median-PS-Value | 0.68 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.32 | |||||
Price-to-Graham-Number | 0.87 | |||||
Price-to-Net-Current-Asset-Value | 1.66 | |||||
Earnings Yield (Greenblatt) % | 10.91 | |||||
FCF Yield % | 0.32 | |||||
Forward Rate of Return (Yacktman) % | 3.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
HPGC Renmintongtai Pharmaceutical Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 10,334.618 | ||
EPS (TTM) (Â¥) | 0.515 | ||
Beta | 0.95 | ||
Volatility % | 24.23 | ||
14-Day RSI | 58.18 | ||
14-Day ATR (Â¥) | 0.19924 | ||
20-Day SMA (Â¥) | 6.448 | ||
12-1 Month Momentum % | -6.37 | ||
52-Week Range (Â¥) | 4.96 - 10.5 | ||
Shares Outstanding (Mil) | 579.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HPGC Renmintongtai Pharmaceutical Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HPGC Renmintongtai Pharmaceutical Corp Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
HPGC Renmintongtai Pharmaceutical Corp Frequently Asked Questions
What is HPGC Renmintongtai Pharmaceutical Corp(SHSE:600829)'s stock price today?
When is next earnings date of HPGC Renmintongtai Pharmaceutical Corp(SHSE:600829)?
Does HPGC Renmintongtai Pharmaceutical Corp(SHSE:600829) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |